407
Views
6
CrossRef citations to date
0
Altmetric
Review

Emerging muscarinic receptor antagonists for the treatment of asthma

, , , & ORCID Icon
Pages 123-130 | Received 11 Feb 2020, Accepted 16 Apr 2020, Published online: 17 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Mario Cazzola, Paola Rogliani, Rossella Laitano, Luigino Calzetta & Maria Gabriella Matera. (2022) Beyond Dual Bronchodilation – Triple Therapy, When and Why. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 165-180.
Read now
Mario Cazzola, Paola Rogliani, Silvio Naviglio, Luigino Calzetta & Maria Gabriella Matera. (2022) An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma. Expert Opinion on Pharmacotherapy 23:10, pages 1205-1216.
Read now
Corrado Pelaia, Claudia Crimi, Nunzio Crimi, Luisa Ricciardi, Nicola Scichilone, Giuseppe Valenti, Ornella Bonavita, Stefano Andaloro, Paolo Morini, Andrea Rizzi & Girolamo Pelaia. (2022) Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma. Expert Review of Respiratory Medicine 16:2, pages 183-195.
Read now

Articles from other publishers (3)

Brian Dean, Geor Bakker, Hiroki R. Ueda, Andrew B. Tobin, Alastair Brown & Richard A. A. Kanaan. (2023) A growing understanding of the role of muscarinic receptors in the molecular pathology and treatment of schizophrenia. Frontiers in Cellular Neuroscience 17.
Crossref
Mario Cazzola & Maria Gabriella Matera. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine 712 728 .
Gandhi F. Pavón-Romero, Nancy Haydée Serrano-Pérez, Lizbeth García-Sánchez, Fernando Ramírez-Jiménez & Luis M. Terán. (2021) Neuroimmune Pathophysiology in Asthma. Frontiers in Cell and Developmental Biology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.